Clik here to view.
Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in...
CHENGDU, China Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient was dosed in another Phase...
View ArticleClik here to view.
CAP検査室認定プログラムが日本で審査員研修の参加機関を拡大
東京 （ビジネスワイヤ） — 米国病理医協会（CAP）とCGIkkは、日本の有力機関に所属する病理医20人を対象とする検査室認定審査員研修を開催しました。9月28日の研修は、CAPに代わって検査室を認定する審査員を地域でさらに増やし、検査室の質と正確性を確保して患者ケアを改善する上で、最初の取り組みとなります。...
View ArticleClik here to view.
Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy...
MALVERN, Pa, & TIANJIN, China Ocugen, Inc., (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on innovative therapies that address rare and underserved eye diseases, has entered...
View ArticleClik here to view.
Celltrion to Launch TemixysTM Double Combination Once-Daily Tablet for HIV...
INCHEON, South Korea Celltrion (KRX:068270) announced that it is launching TemixysTM in the U.S. which were approved in November by U.S. Food and Drug Administration (FDA). Celltrion anticipates...
View ArticleClik here to view.
AVITA Medical Announces Listing on Nasdaq
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in...
View ArticleClik here to view.
ナルコレプシー1型患者でオレキシン2受容体（OX2R）選択的作動薬TAK-925の有効性を初期段階で示す新データを世界睡眠学会で発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
Cognitive Improvement Demonstrated With Xanamem™: Actinogen Medical
SYDNEY Actinogen Medical ASX: ACW (‘ACW’ or ‘the Company’) is delighted to announce results from the XanaHES (Xanamem in Healthy Elderly Subjects) trial. The results demonstrate a significant...
View ArticleClik here to view.
SIRION Biotech to Participate in Major International Industry Conferences
MARTINSRIED, Germany SIRION Biotech GmbH (“SIRION”) today announced its participation in major international conferences this October. SIRION, offering the most comprehensive portfolio of custom...
View ArticleClik here to view.
Nuwiq®の製品概要更新版には個別化予防療法における週2回投与の効果的出血予防に関するデータを掲載
スイス・ラッヘン （ビジネスワイヤ） — オクタファルマは本日、欧州医薬品庁が血友病A患者の個別化予防療法に関する情報を含むNuwiq®の製品概要（SmPC）更新版を承認したと発表しました。更新版SmPCはhttps://www.ema.europa.eu/en/medicines/human/EPAR/nuwiqでご確認できます。...
View ArticleClik here to view.
Kraig Biocraft Laboratories COO Travels to Vietnam to Assist Transition of...
ANN ARBOR, Mich. Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that Jon Rice, the Company’s chief operating officer,...
View ArticleClik here to view.
NMPA Approves IND Application for CT103A, a Fully-human BCMA CAR-T for the...
NANJING, China IASO Biotherapeutics (IASO BIO), a clinical stage biotechnology company advancing the development of innovative therapies for cancer, and Innovent Biologics, Inc. (Innovent)...
View ArticleClik here to view.
富士フイルム：フィリップ・コトラー教授主宰2019ワールドマーケティングサミットにグローバルパートナーとして協賛
東京 （ビジネスワイヤ） — 富士フイルムホールディングス株式会社（社長：助野 健児）(東証:4901)は、2019ワールドマーケティングサミットにグローバルパートナーとして協賛いたします。 ワールドマーケティングサミットは、「近代マーケティングの父」であるノースウェスタン大学...
View ArticleClik here to view.
Fujifilm to Sponsor the World Marketing Summit 2019, Organized by Professor...
TOKYO FUJIFILM Holdings Corporation (President: Kenji Sukeno)(TOKYO:4901) is pleased to announce that it will sponsor the World Marketing Summit 2019 as a global partner. The World Marketing Summit...
View ArticleClik here to view.
Aroa Biosurgery Grows Into Additional Markets With Positive Outcomes From...
AUCKLAND, New Zealand Aroa Biosurgery, the Auckland-based privately held tissue-regeneration company, has this week presented positive outcomes of a new clinical study in Canada performed using its...
View ArticleClik here to view.
MPEG LA、査読論文のNucleic Acid Therapeutics誌への掲載を発表
デンバー （ビジネスワイヤ） — 技術ライセンシングの世界的リーダー企業MPEG LAは本日、Nucleic Acid Therapeutics誌の2019年10月号に、MPEG LA専有のリガンド指向型多重ペイロード・オリゴヌクレオチド送達プラットフォームIncrescent Therapeutics™に関する査読論文が掲載されたと発表しました。 MPEG...
View ArticleClik here to view.
Abiomed Announces 1,000th Patient Treated with Impella in Japan
TOKYO Abiomed (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, announces the 1,000th patient has been treated with the Impella heart pump in Japan. The Impella 2.5 and...
View ArticleClik here to view.
GRAIL Announces Positive Validation Data for Its Multi-Cancer Early Detection...
MENLO PARK, Calif. GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced new data validating the performance of its investigational multi-cancer early detection...
View ArticleClik here to view.
CORRECTING and REPLACING GRAIL Announces Positive Validation Data for Its...
MENLO PARK, Calif. Ninth paragraph, first sentence of the release should read: In the group of more than 20 cancer types, the overall detection rate at 99.3 percent specificity was 55 percent...
View ArticleClik here to view.
Clik here to view.
Nuwiq®产品特性概述更新版纳入每周两次给药个体化预防性治疗有效保护出血的数据
瑞士拉亨 (美国商业资讯)–Octapharma今天宣布，欧洲药品管理局已核准Nuwiq®产品特性概述(SmPC)更新版纳入血友病A患者个体化预防性治疗的信息。此次更新版SmPC的网址是https://www.ema.europa.eu/en/medicines/human/EPAR/nuwiq...
View Article